Form 4 for CVS CVS Health
Accepted 2024-04-03 00:00:00 ET · period of report 2024-04-01 · accession 0001127602-24-012256 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-03 | 2024-04-01 | CVS | Lynch Karen S | Pres, CEO, Dir | F - Tax | $79.56 | -62.0K | 74.7K | -45% | -$4.93M |
| D | 2024-04-03 | 2024-04-01 | CVS | Lynch Karen S | Pres, CEO, Dir | A - Grant | $79.56 | +45.2K | 45.2K | New | +$3.60M |
| D | 2024-04-03 | 2024-04-01 | CVS | Lynch Karen S | Pres, CEO, Dir | A - Grant | $79.56 | +188.1K | 188.1K | New | +$14.96M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-01 | F | D | 61,953 | $79.56 | 74,687 | D | — | — | (F2) Surrender of shares in payment of withholding taxes due upon the vesting and settlement of performance stock units. |
| 2 | Common | Common Stock (Restricted) | 2024-04-01 | A | A | 45,248 | $79.56 | 45,248 | D | — | — | |
| 3 | Derivative | Stock Option | 2024-04-01 | A | A | 188,087 | $79.56 | 188,087 | D | $79.56 · 2025-04-01 to 2034-04-01 | 188,087 Common Stock |